Magnesium sulfate and fetal neuroprotection: overview of clinical evidence
Antenatal administration of magnesium sulfate is an important part of the neuroprotective strategy for preterm infants. Strong evidence from five randomized controlled trials and five meta-analyses has demonstrated that magnesium sulfate, when administered before preterm delivery, significantly redu...
Main Authors: | Clément Chollat, Stéphane Marret |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=12;spage=2044;epage=2049;aulast=Chollat |
Similar Items
-
Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application
by: Clément Chollat, et al.
Published: (2018-04-01) -
Antenatal Magnesium Sulfate for Neuroprotective Effects In Preterm Infants
by: Young lim Oh
Published: (2014-12-01) -
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
by: Dane A. De Silva, et al.
Published: (2018-01-01) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
by: Clément Chollat, et al.
Published: (2017-09-01) -
Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU
by: Mariam Ayed, et al.
Published: (2022-06-01)